Diabetic Retinopathy Market Size Map in 2024: with Subject Matter Expert Advice, Evolutions, Key Strategies | Bayer AG, AbbVie Inc, Oxurion NV
Discover a detailed analysis of the Diabetic Retinopathy Market by Kings Research, Crucial insights are illuminated through vivid graphs, charts, and figures, empowering astute decision-making. The global diabetic retinopathy industry was valued at USD 7,070.7 million in 2023 and is projected to grow from USD 7,759.0 million in 2024 to USD 15,631.4 million by 2031, exhibiting a CAGR...
0 Comments 0 Shares 529 Views 0 Reviews